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Modulation of cellular energy expenditure is funda-
mental to normal and pathological cell growth and
differentiation. Mitochondria stores energy as a pro-
ton gradient across their inner membrane. Uncou-
pling proteins (UCPs) can dissipate the gradient to
produce heat or regulate metabolite fluxes. UCP-
mediated proton currents require fatty acids (FAs)
and are blocked by nucleotides, but the molecular
basis of these processes is unknown. We find, by
nuclear magnetic resonance and functional muta-
genesis, that UCP2 can bind FAs laterally through
its peripheral site, and this intramembrane molecular
recognition is essential for UCP2-catalyzed FA flip-
ping across the membrane, which in turn is essential
for proton translocation. The antagonist GDP binds
inside theUCP2cavity and perturbs its conformation,
which can displace FA from the peripheral site as a
mean of inhibiting proton currents. Our data provide
a biophysical perspective of the intricate interplay
of UCPs, FA, and nucleotides in determining proton
fluxes in mitochondria.
INTRODUCTION
Early studies of energy expenditure in living organisms uncov-
ered a fatty acid (FA)-induced process that uncoupled aerobic
respiration from ADP phosphorylation (Klingenberg, 2010;
Nicholls, 1979; Rafael et al., 1969). These studies led to the iden-
tification of uncoupling protein 1 (UCP1) (originally named ‘‘ther-
mogenin’’), a protein responsible for catalyzing the influx of H+ to
the matrix of mitochondria in a FA-dependent manner (Cannon
et al., 1982; Lin and Klingenberg, 1980, 1982). More specifically,
UCP1 translocates H+ down the H+ concentration gradient,
uncoupling F1F0-driven ADP phosphorylation from the oxidation
of metabolites by dissipating the energy contained in the H+
electrochemical potential—which otherwise can be used for
ATP synthesis—as heat. UCP1 is localized to the inner mem-Cell Mebrane of mitochondria of brown adipose tissue (BAT), a tissue
primarily responsible for nonshivering thermogenesis in newborn
humans and other mammals. Although only small pockets of
UCP1-containing BAT remain in adult humans, it has been
shown that white adipose tissue in humans can be differentiated
into beige adipose tissue, increasing UCP1 expression and en-
ergy expenditure (Almind et al., 2007; Mottillo et al., 2012; Wu
et al., 2012).
Since thediscovery ofUCP1, several sequencehomologshave
been identified with varying tissue distribution and physiological
roles (Krauss et al., 2005). Based on homology (Figure S1 avail-
able online), UCPs belong to a large family of mitochondrial
carriers, which are generally known as solute exchangers that
transport negatively charged substrates such as nucleotides,
carboxylates, and vitamins (Palmieri et al., 2006). Some UCPs,
however, adapted their function to modulate H+ electrochemical
potential in specific tissues,making themspecialmembers in this
family of carriers.UCP1,UCP2, andUCP3havebeenmost exten-
sively studied owing to their biomedical importance. In vitro,
UCP2 showed functional similarities toUCP1; itsH+ translocation
activity requires FA and can be inhibited by purine nucleotides
such as GDP (Jaburek et al., 1999). This activity is, however, not
associated with heat generation, but rather has been implicated
in a range of functions including regulation of metabolism (Pec-
queur et al., 2008) and reduction of reactive oxygen species
production (Ne`gre-Salvayre et al., 1997). In cancers, metabolic
adaptations are required for abnormal cell proliferation (Locasale
et al., 2011; Samudio et al., 2009). UCP2 contributes to themeta-
bolic rewiring of tumors and is associated with tumor growth and
development of resistance to therapeutic agents (Derdak et al.,
2008). Expression of UCP2 in pancreatic b cells is also strongly
correlated with decreased insulin secretion, and UCP2 inactiva-
tion restores the glucose-sensing pathway (Zhang et al., 2001).
Thus, UCP2 inhibition has been sought after as a strategy to treat
type 2 diabetes (Zhang et al., 2006). Similarly, UCP3 is highly ex-
pressed in muscle and has been suggested to play a role in FA
metabolism rather than modulation of mitochondrial membrane
potential (Schrauwen et al., 2002), although its energy dissipation
property appears to be conserved. For example, hyperthermia
in mice induced by 3,4-methylenedioxymethamphetamine
(MDMA), a recreational drug known as ‘‘ecstasy,’’ is linked to
UCP3 activity (Mills et al., 2003). Therefore, enhancing the effecttabolism 20, 541–552, September 2, 2014 ª2014 Elsevier Inc. 541
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vention and management of obesity.
Bothactivatingand inactivatingUCPsmayhave important ther-
apeutic consequences, but the detailed mechanism by which
UCPs translocateH+ remainselusive.UCPactivation is acomplex
process that is not only a function of protein conformation and H+
gradient but also requires FAas coactivator and is inhibitedby nu-
cleotides.Basedon theargument thatC14–C18FAs inmicellesor
membranes have pKa7.5 and that50%of themare unionized,
it was proposed that FA, in its protonated or unionized form,
carries H+ across the inner membrane owing to its fast flip-flop
rate in lipid bilayer (Kamp and Hamilton, 1992). Once the H+ is
released to the matrix, the ionized FA cannot readily flip across
the membrane barrier, and thus, the role of UCPs appears to be
catalyzing the flipping of ionized FA back to the intermembrane
space side for carrying another H+ (Garlid et al., 1996; Skulachev,
1991). This mechanism is known as the protonophoretic model.
Liposome-based H+ flux measurements showed that lauric acid
induces UCP1-mediated H+ efflux that is GDP sensitive (Garlid
et al., 1996). Moreover, both liposome assay and patch-clamp
recording of mitochondria membrane showed UCP1-catalyzed
transport of alkyl sulfonate (ASO), an ionized analog of FA
(Fedorenko et al., 2012; Garlid et al., 1996).
The above studies have demonstrated the ability of UCP1 to
catalyze H+ and FA transport across the membrane, but these
observations lack support at the molecular and structural level.
It is unclear how long-chain FA, which differs significantly from
the typical substrates of mitochondrial carriers (nucleotide and
carboxylate), interacts with UCPs. There is also not a model
describing how GDP blocks FA activation of UCPs. Furthermore,
the current functional data lack the definitive molecular informa-
tion and functional mutagenesis needed to show direct link be-
tween the events of FA and H+ transport. In an earlier study, we
developed a nuclear magnetic resonance (NMR) procedure that
enabled the backbone structure determination of UCP2 (Fig-
ure 1A) reconstituted in mixed detergent/lipid micelles (Berardi
et al., 2011). The structure shows that UCP2 has a similar fold as
the ADP/ATP carrier (Pebay-Peyroula et al., 2003): an open-top
barrel architecture formed with three pseudo structural repeats,
each consisting of two transmembrane (TM) helices (denoted by
‘‘H’’) and an intervening amphipathic helix (‘‘h’’) (Figure 1B).
Here, we show by NMR that FA binds to a peripheral site of
UCP2 between TM helices H1 and H6 near the matrix side of
the protein. NMR data also indicate that GDP binding inside
the UCP2 cavity can allosterically displace FA from the periph-
eral site. Guided by the structural information, we performed
functional mutagenesis and show that mutations that weaken
FA binding reduce UCP2-mediated H+ transport and ASO flip-
ping across lipid bilayer. Moreover, mutations of UCP2 that
reduce ASO flipping also reduce H+ transport. Our structural
and functional data together explain the interplay of FA and nu-
cleotides in determining the H+ translocation function of UCP2.
RESULTS
FA Binds to UCP2, Causing Specific Changes to the
UCP2 Chemical Environment
We first characterized FA-UCP2 interaction by NMR titration.
As in the earlier study (Berardi et al., 2011), we reconstituted542 Cell Metabolism 20, 541–552, September 2, 2014 ª2014 Elseviefunctional murine UCP2 in mixed detergent/lipid micelles
(foscholine-12 [DPC], 14:0 cardiolipin [CL], dimyristoyl-sn-
Glycero-3-Phosphocholine [PC], 1,2-diphytanoyl-sn-glycero-
3-phosphate [PL]) in the presence of 5 mM GDP. GDP is an
inhibitor of UCP2, and it was included earlier to enhance protein
thermo stability for structural studies. The large amount of inhib-
itor is not suitable for FA titration, as it affects FA binding. During
the preparation of the UCP2-FA samples, GDP concentration
was reduced to 50 mM and kept constant at all points of FA titra-
tion. The small amount of GDPmaintained the protein sufficiently
stable for NMR sample preparations. We then performed titra-
tion experiments using C16FA in the presence of 50 mM GDP.
FA was titrated into UCP2 (1 mM) at several FA:UCP2 ratios,
ranging from 0.05 to 20. Residue specific NMR chemical shift
changes, as measured using a series of 3D TROSY-HNCO
spectra (Figure 1C), show clear trend of binding saturation with
the lowest dissociation constant (KD) estimated to be 600 ±
200 mM. The data also show that larger FA-induced chemical
shift changes map primarily to TM helices H1 and H6, but also
parts of H2 and H5 (Figure 1D).
FA Binds to the Periphery of UCP2 and Can Be
Allosterically Displaced by GDP
Chemical shift perturbation could have arisen from ligand
directly and/or binding-induced conformational change. To
directly locate FA, we used a paramagnetic analog of C16FA,
5-Doxyl-C18 FA (NO-FA). Titrating increasing amounts of NO-
FA into UCP2 caused broadening of a small subset of back-
bone resonances (Figure 2A; columns 1 and 2 from the left),
with the greatest paramagnetic relaxation enhancement (PRE)
effects clustered around Leu278 on the lipid-facing side of
H6. The PRE effects are consistent with the chemical shift
changes but are more localized. In addition to the strongly
broadened peaks, there are other regions of the protein that
experience weaker PRE effects. Since FA has very low solubility
in water, it can partition preferentially to detergent micelles
leading to nonspecific PRE effects on the peripheral regions
of the protein.
Separating the specific from nonspecific effects was difficult
because there was no information about functionally relevant
interaction between FA and UCPs. We observed that upon addi-
tion of GDP to the UCP2 NO-FA complex, only a subset of resi-
dues recover peak intensities, suggesting that the binding of
GDP (the antagonist) is displacing the NO-FA from a specific
site. In a reverse PRE experiment, we first saturated UCP2
with NO-FA (NO-FA:UCP2 ratio of 0.5:1), as indicated by the
complete disappearance of certain NMR peaks (e.g., that of
Gly281) (Figure 2A; top second panel) and then recorded the
changes on the PRE effect upon incremental addition of GDP
to the NMR sample. Only a subset of the broadened peaks
showed recovered intensity. For example, the NMR resonance
of Gly281, which is initially reduced to below the noise level by
the NO-FA, recovers to 90% of its original intensity at 10 mM
of GDP (Figure 2A; top panels 3–5), whereas the peak intensity
of Leu78 of H2 is also severely broadened to about 20% but
was not sensitive to increasing concentration of GDP (Figure 2A;
bottom panels 3–5). Moreover, the signal recoveries all demon-
strated sigmoidal profile (Figure 2B). We thus consider the PRE
effects on Gly281 and Gly19 being associated to a functionallyr Inc.
Figure 1. Specific Perturbation of UCP2 Chemical Environment by C16 Fatty Acid
(A) Cartoon representation of a backbone structural model of UCP2 (PDB code: 2LCK) derived fromNMRmeasurements, in which domain I, II, and III are shown in
cyan, yellow, and pink, respectively.
(B) A drawing of UCP2 topology for illustrating the secondary structures and key structural motifs.
(C) Regions of 3D TROSY HNCO of UCP2 for showing the specific chemical shift perturbation upon titrating the protein with C16-FA (the 1H-15N planes are
collapsed in the 13C0 dimension). For residues Gly293 and Gly260, the fitting yields approximate dissociation constant (KD) of 600 ± 200 mM.
(D) Mapping chemical shift changes to the structural model of UCP2. The combined chemical shift deference (Dd = [(uHDdH)
2 + (uN DdN)
2 + (uC DdC)
2 ]1/2 with
uH = 1.00, uN = 0.15, and uC = 0.35) between residue pairs in the wtUCP2-GDP complex (0.6 mM UCP2 and 5 mM GDP) and the wtUCP2-FA complex (0.6 mM
UCP2, 10 mM FA, and 0.05mM GDP) are depicted by a linear color spectrum scale from Dd = 0.5 ppm (green) to Dd = 0.03 ppm (white).
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binding site is consistent with the antagonistic relation between
the activator and inhibitor. The PRE effects on Leu78 and I166
are likely due to nonspecific hydrophobic interactions. The
above analysis was conducted for all severely broadened NMR
resonances and those responded to GDP are mapped onto
the structure (Figure 2C). The results show that the approximate
site of the relevant FA interaction consists of a lipid-facing hydro-
phobic groove between H1 and H6 near the matrix side of UCP2
and a number of basic residues including Arg60 and Lys271
(Figure S2).
FA-Binding and GDP-Binding Support Different
Conformations of H1 and H6 of UCP2
The FA acyl chain likely partitions near the hydrophobic groove,
positioning its carboxylate head group for electrostatic interac-Cell Metion with the peripheral basic residues at the matrix side of the
protein (Figure 3A). As for GDP binding, we previously used
spin-labeled GDP to map the region of GDP interaction in
UCP2. The PRE results indicate that GDP binds deep inside
the hydrophilic cavity of UCP2, with the pyrophosphate group
near the proline kinks (Figure 3B) (Berardi et al., 2011), which
are the key structural signatures of mitochondrial carriers. This
mode of nucleotide binding is consistent with the proposed
ADP binding site in AAC (Dehez et al., 2008; Kunji and Robinson,
2006; Wang and Tajkhorshid, 2008); it is also consistent with
the depth of ATP binding in UCP1 (i.e., near the P-kinks about
midway through the cavity) measured by atomic force micro-
scopy (Zhu et al., 2013). The NMR measurements of FA and
GDP interactionswith UCP2 indicate allosteric interplay between
FA and GDP in which GDP binding inside the cavity can displace
FA from its binding site on the outside.tabolism 20, 541–552, September 2, 2014 ª2014 Elsevier Inc. 543
Figure 2. PRE Measurements for Mapping Interaction between UCP2 and NO-FA and Specific Displacement of NO-FA by GDP
(A) Regions of 2D 1H-15N TROSY HSQC spectrum of UCP2 show specific broadening of NMR peaks by nitroxide-labeled FA (NO-FA) and the recovery of
broadened peaks by the addition of GDP. From the left, the first column shows peaks from the spectrum recorded in the absence of NO-FA and in the presence of
50 mMGDP. The second column shows intensity reduction of Gly19, Leu78, and Gly281 after the addition of 0.25 mMNO-FA. Columns 3–5 are spectra recorded
upon incremental addition of 0.5, 1.0, and 10 mMGDP showing gradual recovery of the NMR resonances of Gly19 and Gly281 with increasing presence of GDP.
Column 6 shows fully recovered NMR peaks upon reducing the spin label with ascorbic acid.
(B) Plots of percent of NMR peak broadening versus log of GDP concentration showing sigmoidal recovery of peak intensities for most of the strongly affected
residues (e.g., G281 and S282), but not for some residues whose peaks are also severely broadened by NO-FA, such as L78.
(C) Mapping of the PRE effects that are sensitive to GDP titration (with sigmoidal profile as shown in [B]) using linear color spectrum scale from complete
broadening (red) to no broadening (white). In this analysis, the NMR peak intensities at 0.25 mM NO-FA and 50 mM GDP concentrations were obtained from 3D
TROSY HNCO spectra.
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Figure 3. Structural Perturbation of FA-
Bound UCP2 by GDP
(A) A model of NO-FA binding to UCP2 based
on the PRE results. The NO-FA is placed such that
(1) the mean distance between the spin-label
(green sphere) and the strongest PRE effects
(red spheres) in Figure 2C is minimized, (2) the
carboxylate group is close to the proximal basic
residues Arg60 and Lys271, and (3) the acyl chain
leans against the hydrophobic groove between H1
and H6. Only the side chains of the basic residues
of UCP2 are displayed in the structure.
(B) A model of NO-GDP binding to UCP2 based on
the PRE results obtained previously in Berardi
et al. (2011). The NO-GDP is placed such that the
spin-label (green sphere) of NO-GDP is close
to the strong PRE effects (blue spheres) and that
the electrostatic interaction between GDP and
charged residues inside the cavity is maximized.
(C) Residue-specific change in RDC upon adding
25 mM GDP to an aligned NMR sample of UCP2
with 10 mM FA. The RDC change is plotted as the
RMS difference in RDCs (y axis) between before
and after the addition of GDP. In this analysis, both
NH and C0Ca RDCs are used and the C0Ca RDCs
are normalized to the NH RDCs.
(D) Mapping RMSD values in (D) onto the UCP2
structure with the linear color spectrum scale from
RMSD = 5.0 Hz (pink) to RMSD = 1.0 Hz (white).
The large RMSD values are clustered around the
FA binding site in (A), indicating conformational
perturbation in this region of the protein.
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conformation and/or dynamics at the FA interaction site. We
thus performed RDC measurements to test this hypothesis, as
RDCs are exquisitely sensitive to rearrangement of helical seg-
ments (Chou et al., 2001). In this experiment, we first weakly ori-
ented UCP2 in DNA nanotube liquid crystal andmeasured RDCs
for the backbone NH and C0Ca bond vectors in the presence of
10 mM FA. A second RDC data set was collected after the addi-
tion of 25 mM GDP to the sample. Comparing the two data sets
shows that the addition of GDP caused substantial changes in
RDCs throughout UCP2, but the large majority of changes occur
in H1 and H6 (Figures 3C and 3D), which is consistent with local
structural perturbation of H1 andH6whenGDP causes displace-
ment of FA. RDC is a function of both structure and dynamics.
Therefore, the changes in RDCs in H1 and H6 could have arisen
from changes in conformation or dynamics or a combination of
both.
FA Binding to the Peripheral Site Is Required for UCP2-
Mediated H+ Translocation
We carried out functional mutagenesis to test whether FA bind-
ing to the NMR-derived site in UCP2 is involved in the process of
H+ translocation. The overall composition of the FA binding site
suggests that if the acyl chain of FA is placed along the hydro-
phobic groove between H1 and H6 (which would be consistent
with its partitioning in a lipid bilayer), then the FA carboxylate
head group would be in position for electrostatic interaction
with one or more of the basic residues in the vicinity (Figure 3A).
These residues include Arg60 in the loop preceding the
amphipathic helix h1 and Lys271 in the G-linker of Domain IIICell Me(Figure S2). We hypothesize that replacing these residues with
uncharged amino acid should reduce UCP2 function by disrupt-
ing FA binding.
The R60S and K271S single mutants as well as the R60S/
K271S double mutant were prepared using our standard UCP2
purification protocol and tested for H+ translocation using a lipo-
some H+ flux assay (Figure 4A). In this assay, a fixed amount of
wild-type (WT) UCP2 or mutants was reconstituted into lipo-
somes that contain the fluorescent pH-sensitive probe 8-hydrox-
ypyrene-1,3,6-trisulfonic acid (HPTS) (Experimental Procedure).
At the beginning of the experiment, the pHs inside and outside
the liposomes are equal, but the internal pH increases due to
H+ efflux driven by a Nernst potential generated by a K+ gradient.
UCP2-FA-mediatedH+ efflux isGDPsensitive; it is the highest for
the WT and is significantly reduced for the mutants (Figure 4B).
We found that each of the R60S and K271S mutations reduces
the initial rate of H+ flux to 40% of the WT value. When the
two mutations are combined, the rate further decreases to
15% of that of the WT. In all three cases, H+ translocation can
be inhibited by 100 mMofGDP, indicating that it is the specific ac-
tivity of UCP2. These results together suggest that FA binding to
the peripheral site of UCP2 between H1 and H6 is at least one of
the required steps in the process of H+ translocation.
In addition to R60S and K271S, we also tested basic residue
mutations farther away from the FA binding site, including single
mutations K16S, R76S, K141T, K241S, K267S, and R279T.
To our surprise, most of the mutations except for K267S
and R76S have significant (>20%) reduction in H+ flux (Figures
4C and S3). This suggests that basic residues both inside and
outside the cavity contribute to UCP2 activity.tabolism 20, 541–552, September 2, 2014 ª2014 Elsevier Inc. 545
Figure 4. Effect of Mutations on UCP2-
Mediated H+ Translocation
(A) Schematic drawing of the liposome-based
assay for measuring UCP2-mediated H+ trans-
location across lipid bilayer. In this assay, UCP2 is
incorporated into liposomes with random inward
and outward orientation, and the pH-sensitive
fluorescent dye, HTPS, is encapsulated in the li-
posomes. Initially, both sides of the bilayer are
maintained at pH 6.0 with 10 mMMES buffer. The
interior solution contains 5 mM KCl and 95 mM
NaCl, whereas the exterior solution contains
100 mM KCl. FA, which is required for UCP2-
mediated H+ flux, is added to the external solution.
To drive H+ efflux, as mediated by UCP2 and FA, a
K+ gradient, or equivalently, membrane potential is
introduced by the addition of 4 mM valinomycin.
The rate of H+ conduction is measured as increase
in fluorescence as H+ leave the liposome lumen.
(B) Time traces of fluorescence change from the
assay in (A). Time points 1 and 2 correspond to the
addition of FA and valinomycin, respectively.
Traces are shown for the WT UCP2 (blue), the
R60S mutant (magenta), the K271S mutant (red),
and the R60S/K271S double mutant (green). The
gray trace is from wtUCP2 liposomes pre-
incubated with 100 mM GDP, and similar traces
of inhibition were observed for the mutants. Esti-
mation of the initial H+ efflux rates using linear
approximation are shown in Figure S3B.
(C) Single mutation position displayed in the
context of the UCP2 structural model. Residues of
which nonconservative mutation caused signifi-
cant reduction in H+ transport are shown in blue.
The mutations that do not affect H+ transport are
shown in green.
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Ionized FA, across Lipid Bilayer
Having identified the site of FA binding and its involvement in H+
translocation, we next developed a new liposome-based assay
to investigate the ability of UCP2 to flip ionized FA across the lipid
bilayer. In this assay, a water-soluble fluorescent FA binding pro-
tein (FABP), for which FA binding shifts the fluorescence emis-
sion wavelength from 432 nm to 505 nm (Richieri et al., 1992),
was encapsulated inside liposomes with incorporated UCP2
(Experimental Procedures). FA was then added to the external
buffer solution. UCP2-catalyzed flipping of FA from the outer to
inner leaflet of the liposome membrane can be monitored, in
principle, by the change in fluorescence emission of the FABP
(Figure 5A). There was, however, a technical issue with this
approach. The pKa of FAs (e.g., oleic acid) in membrane at con-
centrations above their critical micellar concentration is 7.5
(Kamp and Hamilton, 1992). Therefore, at physiological pH, a
significant portion of FAs is protonated or unionized in mem-
brane, and thus FA flip-flop is fast. It has been reported that
t1/2 of flip-flop of unionized oleic acid in lipid vesicle is 23 ±
12 ms (Kamp et al., 1995). The fast flip-flop of FA made it
extremely difficult to capture the initial rate of FA binding to
FABP, as the change in fluorescence saturates >80% within
the time required to mix solutions in our assay (>5 s).
To circumvent the problem, we used the C16 ASO that does
not flip-flop (pKa 1). We found that the FABP also binds ASO546 Cell Metabolism 20, 541–552, September 2, 2014 ª2014 Elseviewith high affinity and binding shifts the emission as in the case
of FA (Figure S4A). Moreover, titrating ASO into UCP2 induced
NMR chemical shift perturbation very similar to that caused
by FA, indicating that ASO and FA both bind to the same pe-
ripheral site of UCP2 (Figures S4B and S4C). In the absence
of UCP2, addition of ASO to the external buffer did not cause
any significant change in the fluorescence (Figure 5B; blue
trace), indicating that ASO flip-flop rate in membrane is very
slow. In the presence of UCP2, however, a sharp change in fluo-
rescence was observed (Figure 5B; red trace), indicating a sharp
increase in ASO flipping. We can conclude that the increased
ASO flipping is catalyzed by UCP2, as the activity can be largely
inhibited by the addition of 100 mM GDP (Figure 5B; orange
trace).
UCP2-Catalyzed FA Flipping Is Required for UCP2-
Mediated H+ Translocation
The proteoliposome assays above show separately that UCP2-
mediated H+ transport requires FA binding and that UCP2 has
the ability to catalyze the flipping of ASO or ionized FA across
the membrane. But the relation between FA flipping and H+
transport, which is the essence of the protonophoretic model,
has not been examined experimentally. We sought to investigate
possible link between this two functions of UCP2 by comparing
their sensitivities to various mutations. We tested an extensive
collection of mutations for their effect on UCP2-catalyzedr Inc.
Figure 5. Effects of Mutations on UCP2-Catalyzed ASO– Flipping
(A) Schematic drawing illustrating the design of the liposome-based assay for measuring UCP2-catalyzed flipping of ASO across lipid bilayer. In this assay,
UCP2 is incorporated into liposomes with random orientation, and the fluorescent FABP, which also binds ASO, is encapsulated in the liposomes at about 1 mM
FABP per liposome. Addition of ASO to the external solution leads to spontaneous partitioning of ASO in the outer leaflet of the liposome. If UCP2 can catalyze
the flipping of ASO across the lipid bilayer, then ASO can bind FABP in the liposome lumen, which causes a shift in the fluorescence emission peak from 432 to
505 nm. To drive ASO flipping in the assay, a K+ gradient, or equivalently, membrane potential, is introduced by the addition of valinomycin to the liposome. The
interior solution contains 5 mM KCl and 95 mM NaCl, whereas the exterior solution contains 100 mM KCl, in a 10 mM MES buffer at pH 6.0.
(B) Time traces of fluorescence change from the assay in (A). After the addition of 100 mMASO (1) and 4 mMvalinomycin (2) to the external solution, the liposomes
without UCP2 shows insignificant change in fluorescence (blue). Liposomes with UCP2 showed a sharp drop in fluorescence emission (red). To test inhibition by
GDP, 100 mM GDP was added and followed by mild sonication to allow equilibration of GDP between inside and outside of the liposome. GDP caused >90%
inhibition of ASO flipping (orange).
(C) Bar graph for comparing the rates of ASO flipping by UCP2 variants in the absence and presence of GDP. The rates are calculated for the traces shown in
(Figure S5B) by fitting to a single exponential model using the program Origin.
(D) Correlation between reduction in ASO flipping and reduction in H+ translocation caused by various mutations. The reduction relative to the WT is defined as
(RateWT  RateMUT) / RateWT.
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FA binding site but also more remote sites inside and outside
the hydrophilic cavity of the protein, including those believed
to involve in GDP binding (Figures 5C and S4D; Table S1). For
the subset of mutations that overlap with those tested for H+
flux (Figure 4), their effects of reducing ASO flipping correlate
strongly with that of reducing H+ flux, with a correlation coeffi-
cient of 0.8 (Figure 5D). This observation provides strong evi-
dence showing that UCP2-catalyzed FA flipping is required for
H+ translocation.
Positively Charged Residues Inside and Outside UCP2
Cavity Are Important for ASO– Flipping
The effects of mutations (Figures 5C and S4D) can be grouped
into four categories. One effect is significant reduction of ASO
flipping but not GDP inhibition. Mutations that cause this effect
include the single mutations R60S, K271S, K241S, R279T, andCell MeK16S and the double mutation R60S/K271S. The peripheral
basic residues Arg60 and Lys271 are in position for electrostatic
interaction with the acidic head group of ASO (Figure 6A).
Therefore, mutating each or both of them to serine may have
reduced ASO flipping simply by affecting initial docking of
ASO to the specific site on UCP2. The three other mutations,
K241S, R279T, and K16S, are not straightforward to understand,
as they do not appear to be directly interacting with ASO in the
current structural model of UCP2. Among them, Lys241 and
Arg279 are close to the FA binding site and thus may contribute
to the electrostatic potential that recruits ASO, but Lys16 is
located on the opposite side of the protein. Another effect is sig-
nificant reduction of GDP inhibition but not ASO flipping. The
only mutation we tested that causes this effect is R185T of H4.
According to the GDP binding model proposed earlier (Berardi
et al., 2011), Arg185 is in position for charge-charge interaction
with GDP inside the cavity (Figure 6B). Mutating Arg185 totabolism 20, 541–552, September 2, 2014 ª2014 Elsevier Inc. 547
Figure 6. Effects of Mutations on ASO– Flipping: Importance of Positively Charged Residues
(A) Mutations that caused significant reduction of ASO flipping but not GDP inhibition.
(B) Mutations that caused significant reduction of GDP inhibition but not ASO flipping.
(C) Mutations that caused significant reduction for both GDP inhibition and ASO flipping.
(D) Mutations that affected neither ASO flipping nor GDP inhibition.
(E) Single mutation position displayed in the context of the UCP2 structural model. Residues of which nonconservative mutation caused significant reduction in
ASO flipping are shown in blue. The mutations that do not affect H+ transport are shown in green.
(F) Average electrostatic potential of the 15 low-energy conformations of UCP2 (PDB code: 2LCK) calculated using the program Delphi (Li et al., 2012) and
presented as a density map. For clarity, only the positive component (blue) of the electrostatic potential map is displayed, which shows strong and continuous
positive charge distribution from the periphery to the cavity of UCP2.
The model used in this figure is the NMR-derived backbone structure of UCP2 in the presence of GDP (PDB code: 2LCK). It is not the conformation of the
FA-bound UCP2. The NO-FA and NO-GDP are shown to provide reference points for the mutations.
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tion by GDP. In addition to Arg185, the cavity-lining basic resi-
dues, Arg88 of H2 and Lys141 of H3, also appear to participate
in GDP binding in the model (Figure 6C). Indeed, mutating them
to threonine causes significant decrease in inhibition by GDP.
But, unlike the R185T mutation, the R88T and K141T mutations,
which are far away from the FA binding site, also cause signifi-
cant reduction in ASO flipping. Finally, several mutations affect
neither ASO flipping nor GDP inhibition, and these include
R76S, I30A, and L278A (Figure 6D).
The mutational effects above are overall consistent with FA
recruitment to the peripheral site between H1 and H6 via electro-
static interaction. But, in addition to the peripheral residues such
as R60, K271, and R241, several basic residues inside the cavity
including K16, R88, K141, and R279 also appear to contribute
significantly to ASO flipping in our assay (Figure 6E). These
basic residues may facilitate ASO flipping by contributing to
the positive potential (Figure 6F) that draws the acidic head
group of ASO into the UCP2 cavity. On the other hand, the
I30A and L278A mutations in the hydrophobic groove between548 Cell Metabolism 20, 541–552, September 2, 2014 ª2014 ElsevieH1 and H6 do not affect ASO flipping, suggesting that hydro-
phobic interaction with the acyl chain of ASO is not a determi-
nant of specific ASO-UCP2 recognition. In theory, the acyl
chain of FA or ASO is a poor molecular target for specificity in
the lipid bilayer, given the large presence of lipid acyl chains
around the protein. Our mutagenesis data suggest that the
ionized head group of FA holds the specificity for binding and
flipping and that basic residues both inside and outside UCP2
cavity constitute an electrostatic path (Figure S5) for the initial
recognition of ASO and subsequent transport through the
cavity.
DISCUSSION
Amodel for UCP2 activation by FA and inhibition by GDP can be
constructed based on the conclusions drawn from our NMR and
functional data as well as previously published results (Figure 7).
Protonated FA carries H+ from the outer to inner face of the inner
membrane. Upon releasing the H+ to the matrix, the ionized FA
binds specifically to a peripheral site of UCP2 between the H1r Inc.
Figure 7. A Model for the Interplay Among FA, UCP2, and GDP in Modulating H+ Translocation Across the Mitochondrial Inner Membrane
(A) Protonated or unionized FA readily undergo flip-flop that carries H+ across the lipid bilayer. Upon releasing the H+ to the matrix, the ionized FA is recruited to
the peripheral binding site of UCP2 via electrostatic interaction.
(B) Binding FA causes minor structural change in UCP2 that allows the acidic head group of FA to enter the cavity of UCP2.
(C) Upon entering the cavity, the acidic head group of FA is retained by the strong positive charge potential of the cavity while being driven across the UCP2 by the
strong membrane potential.
(D) GDP binding inside the cavity can allosterically displace FA from its binding site, which prevents FA flipping by U0043P2 and thus makes H+ shuttling by FA
unsustainable.
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shown earlier to bind inside the UCP2 cavity, can displace FA
from its peripheral site. The RDC measurements indicate that
the antagonistic effect of GDP is due to an allosteric mechanism
by which GDP binding induces changes in conformation and/or
dynamics of H1 and H6 such that the peripheral site for FA is
adversely disrupted. The different structures compatible with
FA and GDP binding is consistent with earlier observation that
FA and GDP impose opposite effects on UCP2 activity (i.e.,
GDP inhibits FA-UCP2-mediated H+ conduction in proteolipo-
somes, but the inhibition can be reversed by increasing FA con-
centration) (see Figure S2e of Berardi et al., 2011). The cellular
concentration of free GDP/GTP is 100–500 mM (Traut, 1994). Ac-
cording to our observation of complete inhibition of UCP2 activ-
ity at 100 mMGDP, we expect UCP2 to be constitutively inhibited
by the free GDP. It is possible that the physiological role of GDP
inhibition is to constitutively suppress the activity of UCP2 unless
activated by a surge of free FA that enter the mitochondria.
The liposome-based functional assays show that UCP2 can
catalyze the flipping of C16 ASO across the membrane, and
this activity can be inhibited byGDP. Although the time resolution
of the assay is only sufficient for measuring UCP2-mediated flip-
ping of ASO, we argue that the same activity of UCP2 should
apply to ionized FA because (1) ASO binds to the same site inCell MeUCP2asFA, as indicatedbyNMR titrationdata, and (2)mutations
in UCP2 that weaken FA binding also reduce the rate of UCP2-
mediated ASO flipping. Furthermore, mutations that reduce
UCP2-catalyzed ASO flipping also reduce FA-UCP2-mediated
H+ flux. These results together indicate that FA binding to
UCP2 and FA flipping by UCP2 are tightly coupled to H+ translo-
cation, which in turn suggests that H+ from the intermembrane
space are carried across the inner membrane as a part of union-
ized FA and UCP2 allows the recycling of ionized FA. This mech-
anism is consistent with the previous observation that UCP1-
mediated H+ translocation in the presence of FA can be inhibited
by addition of ASO (Garlid et al., 1996), which competeswith FA
for binding to UCP but does not carry H+ at physiological pH.
The current data cannot provide details of the dynamic
changes in UCP2 during the FA flipping process. We believe
that in order for the ionized FA to flip across themembrane within
functionally relevant timescale, the charged carboxylate head
group must enter the hydrophilic cavity to circumvent the hydro-
phobic barrier of the lipid bilayer. In this case, FA first docks at
the peripheral site via electrostatic interactions between its
head group and the surface-exposed basic residues at the bind-
ing site between H1 and H6. After initial docking in the vicinity of
residues Arg60 and Lys271, the acidic head group can enter the
cavity by interacting with other basic residues inside the cavitytabolism 20, 541–552, September 2, 2014 ª2014 Elsevier Inc. 549
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and H6 between the FA- and GDP-bound states, as indicated by
RDC data, suggests that this region of UCP2 has the conforma-
tional variability to undergo the necessary changes to allow easy
entrance of the FA head group.
In summary, the model presented in Figure 7, in which UCP2
acts more as a FA flippase than a H+ conductor, provides
physical and molecular basis of the interplay of FA and GDP in
modulating UCP2-mediated H+ translocation. UCP2 belongs to
a family of mitochondrial carriers whose canonical function is
transporting negatively charged substrates such as carboxyl-
ates and nucleotides. The FA cycling mechanism proposed
earlier for UCP1 (Garlid et al., 1996) suggests an intriguing
exception: rather than transporting soluble substrate, UCP1 cat-
alyzes the flipping of ionized FA partitioned in the membrane,
which indirectly allow for sustained shuttling of H+ by FA.
We show that long-chain FA in hydrophobic environment can
directly bind to UCP2 at a peripheral site and that such binding
is essential for UCP2-mediated H+ translocation and FA flipping.
UCP2 is thus a special carrier protein that has developed the
ability to recruit the acidic carboxylate of FA laterally from within
the membrane, rather than receiving substrates longitudinally
from either side of the membrane as in the classic alternating
access mechanism of solute carriers. While the peripheral basic
residues mediate FA recognition through charge-charge interac-
tions, the external charge potential continues into and through
the UCP2 cavity due to the basic residues inside. UCP2 appears
to have adopted the electrostatic potential to attract the acidic
head group of FA into the cavity and to facilitate its transport
during FA flipping.
It is not surprising that UCP2 can also bind nucleotides such as
GDP, because it has over 20% sequence identity with the ADP/
ATP carrier. But, UCP2 has evolved to bind the nucleotides but
not transport them, in which case the substrates become inhib-
itors. We show that GDP binding in the UCP2 cavity can alloste-
rically displace FA from its binding site on the periphery,
which prevents FA flipping and thus H+ translocation. The newly
described physical basis of UCP2 activation by FA and inhibition
by GDP demonstrates the remarkable evolution of a mitochon-
drial carrier, which possibly transformed a nucleotide transport
mechanism into a regulatory component of a FA flippase activity
while preserving the overall architecture of the carrier proteins.
EXPERIMENTAL PROCEDURES
Expression and Purification of UCP2
Mouse UCP2 (residues 14–309 with a C-terminal His6 tag) was expressed
using a pET-21 vector in E. Coli Rossetta DE3 cells and purified as in previous
study (Berardi et al., 2011). A more detailed protocol used for protein prepara-
tion in this study is in Supplemental Experimental Procedures.
NMR Titration Experiments
The UCP2-FA samples were prepared using the UCP2-GDP NMR sample as a
starting point. First, the buffer was exchanged using aG25 column equilibrated
in Buffer C (30 mM potassium phosphate, 0.1% DPC, 0.05 mM GDP, and
80 mM NaCl [pH 6.5]). The UCP2-containing fraction was concentrated to
0.6 mM protein and then dialyzed against Buffer C using a 10 kD MW cutoff
membrane. FA or ASO was added to the desired concentrations using a
100 mM stock solutions in 200 mM potassium phosphate (pH 6.5) and 2%
DPC. For PRE experiments, we used a stock dispersion at 2.5 mM of FA-NO
(5-DOXYL-stearic acid, Sigma) in 30 mM potassium phosphate (pH 6.5) and550 Cell Metabolism 20, 541–552, September 2, 2014 ª2014 Elsevie1% DPC. Displacement of NO-FA by GDP was performed using a 0.6 mM
UCP2 sample initially containing 0.3 mM NO-FA. GDP was added directly to
the NMR sample as a stock solution (400 mM GDP [pH 6.5] and 0.1% DPC)
to reach 0.1, 0.5, 1.0, 5.0, and 10 mM final GDP concentrations.
Since FA-induced chemical shift changes are overall small, the backbone
resonance assignments of the FA-bound UCP2 could be traced from those
of GDP-bound UCP2 from earlier study (Berardi et al., 2011) by recording a
series of 3D HNCO-TROSYs at different FA concentrations. The assignments
of FA-bound UCP2 were also validated using a 3D HNCA-TROSY spectrum.
NMR RDC Measurement
RDC measurements were conducted using UCP2 weakly aligned in DNA
nanotube liquid crystal, as described in previous studies (Berardi et al.,
2011; Douglas et al., 2007) (details in Supplemental Experimental Procedures).
To prepare the aligned UCP2 sample, wemixed 300 ml of 25 mg/ml DNA nano-
tubes and 300 ml of 0.5 mM 15N/13C/2H-labeled UCP2 sample containing
50 mM GDP, 10 mM C16FA, 100 mM DPC, 10 mM potassium phosphate
(pH 6.5), and 80 mM NaCl. The mixture was concentrated down to 280 ml.
The HDO of the final aligned sample showed 2H quadrupolar splitting of
3.8 Hz. The same sample was thenmade to contain 25mMGDPwhile all other
components were kept fixed. This sample showed 2H quadrupolar splitting of
3.6 Hz. The RDCs in the presence of GDP are thus scaled by the factor 3.8/3.6.
The H+ Translocation Assay
The UCP2 proteoliposomes were first made using a lipid composition of
DOPC:DOPG:DOPE:CL (Avanti) at 20:5:1:1 molar ratio. A lipid solution con-
taining 20 mg lipids/ml dissolved with 10% detergent (1:1 ratio of DM:OG)
was prepared using Buffer D (10 mM MES, 95 mM NaCl, and 5 mM KCl
[pH 6.0]). A 0.5 mM UCP2 sample in NMR buffer was mixed with the lipid so-
lution at 400:1 lipid:protein ratio and then diluted 203 to a lipid concentration
of 1mg/ml with Buffer D in the presence of 10 mMHPTS (Sigma), a fluorescent,
pH-sensitive probe. Detergent removal was performed twice using a G25
desalting column equilibrated with Buffer D. The resulting proteoliposomes
contained the fluorescent probe and were stable at room temperature. The
proteoliposome solution was further diluted 103–153 with Buffer D (10 mM
MES and 100 mM KCl [pH 6.0]).
For measuring H+ translocation, 100 mM C16-FA was added to the external
solution because FA is required for UCP2 activity. In addition, 1 mM valinomy-
cin (Sigma) was added to the external solution to establish K+ electrochemical
potential to drive H+ efflux. At the beginning of the experiment, pHs inside and
outside of the proteoliposomes are equal. UCP2-mediated H+ translocation
resulted in internal pH increase, observed as a function of the HPTS flores-
cence intensity at 510 nm (lex 460 nm) using a dual monochromator fluorom-
eter equipped with a photomultiplier detection system (PTI, Model 814). For
measuring GDP inhibition, 100 mM GDP was added to the external solution.
The ASO– Flipping Assay
In this assay, UCP2 proteoliposomes were made using a similar protocol as in
the H+ translocation assay except the fluorescent probe to be encapsulated is
a water-soluble, acrylodan-labeled FABP (ADIFAB, FFA Sciences) (Richieri
et al., 1992), for which FA or ASO binding shifts the fluorescence emission
wavelength from 432 nm to 505 nm. Again, the lipid composition used is
DOPC:DOPG:DOPE:CL at 20:5:1:1 ratio. A lipid solution containing 20 mg
lipids/ml dissolved with 10% detergent (1:1 ratio of DM:OG) was prepared us-
ing Buffer E (10 mM HEPES, 95 mM NaCl, 5 mM KCl, and 0.5 mM EGTA
[pH 7.0]). EGTA was added to increase reproducibility, since the fluorescence
of ADIFAB is sensitive to Ca2+. A 0.5 mM UCP2 sample in NMR buffer, pre-
treated with Bio-Beads SM-2 to remove endogenous FA, was mixed with
the lipid solution at 400:1 lipid:protein ratio and then diluted 203 to a lipid con-
centration of 1 mg/ml with Buffer E plus 2 mMADIFAB. Detergent removal was
performed by loading 500 ml of the protein/lipid/detergent solution onto a long
G-50 Sephadex column equilibrated with Buffer E. Only the front 30% of the
elution peak containing proteoliposomes was used in the assay. Well-formed
liposomes ranging from 100 to 250 nm were observed using electron micro-
scopy. The proteoliposome solution was further diluted 103 with Buffer F
(10 mM HEPES, 100 mM KCl, and 0.5 mM EGTA [pH 7.0]).
For measuring ASO flipping, 100 mM ASO was added to the external
solution, which was immediately followed by the addition of 4 mM valinomycinr Inc.
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ping of ASO from the outer to inner leaflet of the liposomemembrane resulted
in ASO binding to ADIFAB, which was monitored at 435 nm (lex 380 nm)
using a spectrofluorometer (PTI, Model 814). The UCP2 proteoliposomes
showed sharp decrease in emission at 435 nm upon the addition of ASO
and valinomycin. UCP2-free liposomes, however, did not produce significant
changes in fluorescence, indicating that ASO does not flip by itself. For GDP
inhibition, UCP2 proteoliposomes were first incubated with Buffer E in the
presence of 100 mM GDP and were sonicated for 10 s in a bath sonicator
(Branson 2510) to equilibrate the GDP inside the liposomes. This resulted
in 95% inhibition of the wtUCP2-catalyzed ASO flipping. Addition of 4 mM
valinomycin and 100 mM ASO to the sonicated UCP2-free liposomes did
not produce significant changes in fluorescence, indicating that ADIFAB leak
is negligible.
Statistical Analysis
For liposome assays, the initial transport rates of pooled experiments are
expressed as the mean value (m) ±SD (s). In the ASO/H+ transport correlation
plot (Figure 5), the error in the ratio of ASO flipping of mutant to WT is given
by (mMut/mWT) [(sMut/mMut)2 + (sWT/mWT)2]1/2. For NMR titration experiments,
percent error in peak intensity is given by the inverse of the signal to noise
(S/N) ratio. On average, the S/N ratio of the analyzed peaks is 55.8 ± 37.9.
For RDC measurements, only peaks with S/N ratio >8 are used.
SUPPLEMENTAL INFORMATION
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